|
市場調査レポート
商品コード
1402488
北米の脳深部刺激療法市場の2030年までの予測- 地域別分析- 製品、用途、エンドユーザー別North America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User |
||||||
|
|
|||||||
|
|||||||
| 北米の脳深部刺激療法市場の2030年までの予測- 地域別分析- 製品、用途、エンドユーザー別 |
|
出版日: 2023年10月27日
発行: The Insight Partners
ページ情報: 英文 82 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
北米の脳深部刺激療法市場は、2022年の2億8,286万米ドルから2030年には5億4,978万米ドルに成長すると予測されています。2022年から2030年までのCAGRは8.7%と推定されます。
神経疾患の増加が北米の脳深部刺激療法市場を牽引
高齢者人口は神経疾患にかかりやすいです。神経障害、パーキンソン病、アルツハイマー病、ジストニアは、高齢者が罹患する最も一般的な神経疾患のひとつです。米国国立衛生研究所（NIH）によると、世界人口の8.5％（すなわち約6億1,700万人）が65歳以上です。米国やカナダなどの国々では、高齢者人口の増加に伴う運動障害や精神疾患の有病率が高いです。パーキンソン財団によると、パーキンソン症状は平均年齢60歳でよくみられます。カナダ心理学会によると、人口の約2％が強迫性障害（OCD）に苦しんでいます。世界保健機関（WHO）によると、神経疾患は世界の疾病負担の6.3％を占めており、世界中で主要な死因の一つとなっています。また、先進国では死亡原因の13.2%、中低所得国では16.8%が神経疾患であると報告されています。高い死亡率と疾病負担から、脳深部刺激療法（DBS）のような長期的な解決策を統合することが臨床的に急務となっています。したがって、神経疾患の負担に関する意識の高まり、高齢者人口の増加、神経疾患の有病率の増加が、治療としての脳深部刺激療法に対する需要を促進しています。
北米の脳深部刺激市場概要
パーキンソン病（PD）などの神経疾患の有病率の上昇、神経疾患に対する意識の高まり、前向きな研究成果、経頭蓋刺激装置の開発への投資の増加は、米国における脳深部刺激療法市場全体の成長を促進する主要要因の一つです。脳深部刺激（DBS）装置は、パーキンソン病に伴う震えの抑制に有効であることが確認されています。ドーパミンレベルの低下やその他の遺伝的要因は、パーキンソン病の主要原因のひとつです。アルツハイマー病協会（Alzheimer's Association）が発表した「2022 Alzheimer's disease facts and figures」と題された調査によると、2022年には65歳以上のアメリカ人の約650万人がアルツハイマー病に罹患していることが判明しており、その数は2060年までに1,380万人に増加すると予測されています。技術の進歩と新製品の発売が米国脳深部刺激療法市場の成長を牽引しています。2020年1月、AbbottのInfinity DBSシステムがパーキンソン病治療用として米国食品医薬品局（FDA）の承認を取得しました。このシステムは、パーキンソン病の症状に関連する内側淡蒼球（GPi）と呼ばれる脳の特定部位を標的として治療できます。米国FDAは2017年12月、Boston Scientific Corporationが使用するパーキンソン病治療用脳深部刺激療法システム「Verses」を承認しました。パーキンソン財団によると、米国では約100万人がパーキンソン病を患っており、2030年には120万人に増加すると予想されています。したがって、神経疾患の有病率の増加と技術の進歩が、米国における北米の脳深部刺激療法市場の成長を後押ししています。
北米の脳深部刺激療法市場の収益と2030年までの予測（金額）
北米の脳深部刺激療法市場セグメンテーション
北米の脳深部刺激療法市場は、製品、用途、エンドユーザー、国に区分されます。
製品別では、北米の脳深部刺激療法市場は、シングルチャンネル脳深部刺激療法、デュアルチャンネル脳深部刺激療法、ソフトウェアとアクセサリーに区分されます。2022年には、デュアルチャンネル深部脳刺激装置セグメントが北米脳深部刺激療法市場で最大のシェアを記録しました。
用途別では、北米の脳深部刺激療法市場は、パーキンソン病、振戦、ジストニア、てんかん、アルツハイマー病、その他に区分されます。2022年、パーキンソン病セグメントは北米の脳深部刺激療法市場で最大のシェアを記録しました。
エンドユーザー別では、北米の脳深部刺激療法市場は病院、神経科クリニック、外来手術センター、その他に区分されます。2022年、北米の脳深部刺激療法市場では、病院セグメントが最大のシェアを記録しました。
国別では、北米の脳深部刺激療法市場は米国、カナダ、メキシコに区分されます。2022年、米国は北米の脳深部刺激療法市場で最大のシェアを記録しました。
Abbott Laboratories、Boston Scientific Corp、Medtronic Plc、Newronika SpAなどが北米の脳深部刺激療法市場で事業を展開している大手企業です。
目次
第1章 イントロダクション
第2章 エグゼクティブサマリー
- 主要洞察
- 北米の脳深部刺激療法市場：地域別
第3章 調査手法
- 調査範囲
- 2次調査
- 1次調査
第4章 北米の脳深部刺激市場情勢
- イントロダクション
- 北米PEST分析
- 比較分析
- 脳深部刺激療法と病変形成手技の比較
- 神経疾患における病変形成手順
- 2022年に実施される脳深部刺激手術の国別手順
第5章 北米の脳深部刺激療法市場：主要産業力学
- 主要市場の促進要因
- 神経疾患の有病率の上昇
- 低侵襲手術に対する需要の増加
- 市場抑制要因
- 脳深部刺激に伴う副作用
- 市場機会
- 脳深部刺激療法における技術の進歩と承認
- 今後の動向
- 研究開発の活発化
- 影響分析
第6章 脳深部刺激市場：北米市場分析
- 北米の脳深部刺激療法市場売上高、2022～2030年
第7章 北米の脳深部刺激療法市場：製品別収益と2030年までの予測
- イントロダクション
- 北米の脳深部刺激装置市場の2022年と2030年の製品別売上高シェア（%）
- シングルチャンネル脳深部刺激療置
- デュアルチャンネル脳深部刺激置
- ソフトウェアと付属品
第8章 北米の脳深部刺激療法市場：用途別収益と2030年までの予測
- イントロダクション
- 北米の脳深部刺激療法市場：2022年と2030年の用途別売上高シェア（%）
- パーキンソン病
- 振戦
- アルツハイマー病
- ジストニア
- てんかん
- その他
第9章 北米の脳深部刺激療法市場：エンドユーザー別収益と2030年までの予測
- イントロダクション
- 北米の脳深部刺激療法市場：2022年と2030年のエンドユーザー別売上高シェア（%）
- 病院
- 神経クリニック
- 外来手術センター
- その他
第10章 北米の脳深部刺激療法市場：国別分析
- 概要
- 北米の脳深部刺激療法市場：国別
- 米国
- カナダ
- メキシコ
第11章 COVID-19前後の影響
- COVID-19前後の影響
第12章 脳深部刺激療法市場の業界情勢
- イントロダクション
- 脳深部刺激療法市場の成長戦略
- 有機的成長戦略
- 概要
- 無機的成長戦略
- 概要
第13章 北米の脳深部刺激療法市場：主要企業プロファイル
- Abbott Laboratories
- Medtronic Plc
- Boston Scientific Corp
- Newronika SpA
第14章 付録
List Of Tables
- Table 1. North America Deep Brain Simulation Market Segmentation
- Table 2. Comparison of Deep Brain Stimulation and Lesioning Procedures
- Table 3. Deep Brain Stimulation Surgical Procedures Performed in 2022, by Country.
- Table 4. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
- Table 5. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
- Table 6. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
- Table 7. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
- Table 8. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
- Table 9. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
- Table 10. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
- Table 11. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
- Table 12. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
- Table 13. Recent Organic Growth Strategies in Deep Brain Stimulation Market
- Table 14. Recent Inorganic Growth Strategies in the North America deep brain simulation market
- Table 15. Glossary of Terms, North America Deep Brain Simulation Market
List Of Figures
- Figure 1. North America Deep Brain Simulation Market Segmentation, By Country
- Figure 2. North America - PEST Analysis
- Figure 3. North America Deep Brain Simulation Market - Key Industry Dynamics
- Figure 4. Impact Analysis of Drivers and Restraints
- Figure 5. North America Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030
- Figure 6. North America Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
- Figure 7. Single Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 8. Dual Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 9. Software and Accessories: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 10. North America Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
- Figure 11. Parkinson's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 12. Tremor: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 13. Alzheimer's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 14. Dystonia: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 15. Epilepsy: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 16. Others: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 17. North America Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
- Figure 18. Hospitals: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 19. Neurology Clinics: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 20. Ambulatory Surgical Centers: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 21. Others: Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 22. North America Deep Brain Simulation Market, 2022 ($Mn)
- Figure 23. North America Deep Brain Simulation Market, By Key Countries, 2022 And 2030 (%)
- Figure 24. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
- Figure 25. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
- Figure 26. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
- Figure 27. Pre & Post Covid-19 Impact
- Figure 28. Growth Strategies in Deep Brain Stimulation Market
The North America deep brain simulation market is expected to grow from US$ 282.86 million in 2022 to US$ 549.78 million by 2030. It is estimated to grow at a CAGR of 8.7% from 2022 to 2030.
Rising Prevalence of Neurological Disorders Drive North America Deep Brain Simulation Market
The geriatric population is susceptible to neurological diseases. Neuropathy, Parkinson's disease, Alzheimer's disease, and dystonia are among the most common neurological disorders affecting older people. According to the National Institutes of Health (NIH), 8.5% of the world's population (i.e., around 617 million people) are 65 and above. Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson's Foundation, Parkinson's symptoms are common at an average age of 60. The Canadian Psychological Association states that about 2% of the population suffers from obsessive-compulsive disorder (OCD). According to the World Health Organization (WHO), neurological diseases contribute 6.3% to the global disease burden and are one of the leading causes of death across the world. In addition, 13.2% of deaths in developed countries and 16.8% in low- and middle-income countries are reported due to neurological diseases. High mortality and disease burden necessitate the clinical urgency for integrating long-term solutions such as deep brain stimulators (DBS). Therefore, growing awareness regarding the burden of neurological disorders, the growing geriatric population, and the increasing prevalence of neurological diseases propel the demand for deep brain stimulators as a therapy.
North America Deep Brain Simulation Market Overview
The rising prevalence of neurological diseases such as Parkinson's disease (PD), increasing awareness about neurological disorders, positive research results, and growing investments in developing transcranial stimulators are among the main factors driving the overall deep brain stimulation market growth in the US. Deep brain stimulation (DBS) devices have been observed to be effective in controlling the tremors associated with Parkinson's disease. Low dopamine levels and other genetic factors are among the main causes of Parkinson's disease. According to a study titled "2022 Alzheimer's disease facts and figures" published in the Alzheimer's Association, nearly 6.5 million Americans aged 65 and above were found to have Alzheimer's disease in 2022, and that number is projected to rise to 13.8 million by 2060. Technological advancements and new product launches drive the growth of the US deep brain stimulation market. In January 2020, Abbott's Infinity DBS System received US Food and Drug Administration (FDA) approval for treating Parkinson's disease. This system allows for the targeted treatment of a specific area of the brain, called the inner globus pallidus (GPi), which is associated with the symptoms of Parkinson's disease. The US FDA approved the Verses deep brain stimulation device system for treating Parkinson's disease in December 2017 for use by Boston Scientific Corporation. According to the Parkinson's Foundation, around 1 million people in the US are suffering from Parkinson's disease, which is expected to increase to 1.2 million by 2030. Therefore, the increasing prevalence of neurological diseases and technological advancements fuel the North America deep brain simulation market growth in the US.
North America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)
North America Deep Brain Simulation Market Segmentation
The North America deep brain simulation market is segmented into product, application, end user, and country.
Based on product, the North America deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the North America deep brain simulation market.
Based on application, the North America deep brain simulation market is segmented into Parkinson's disease, tremor, dystonia, epilepsy, Alzheimer's disease, and others. In 2022, the Parkinson's disease segment registered the largest share in the North America deep brain simulation market.
Based on end user, the North America deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the North America deep brain simulation market.
Based on country, the North America deep brain simulation market is segmented into the US, Canada, Mexico. In 2022, the US registered the largest share in the North America deep brain simulation market.
Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, and Newronika SpA are some of the leading companies operating in the North America deep brain simulation market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America deep brain simulation market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America deep brain simulation market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the deep brain simulation market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
- 2.2 North America Deep Brain Stimulation Market, by Region (US$ Million)
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Deep Brain Simulation Market Landscape
- 4.1 Overview
- 4.2 North America PEST Analysis
- 4.3 Comparison Analysis
- 4.3.1 Comparison of Deep Brain Stimulation and Lesioning Procedures
- 4.3.2 Lesioning Procedures in Neurological Disorders
- 4.3.3 Deep Brain Stimulation Surgical Procedures Performed in 2022, By Country
5. North America Deep Brain Simulation Market - Key Industry Dynamics
- 5.1 Key Market Drivers:
- 5.1.1 Rising Prevalence of Neurological Disorders
- 5.1.2 Increasing Demand for Minimally Invasive Surgery
- 5.2 Market Restraints
- 5.2.1 Side Effects Associated with Deep Brain Stimulation
- 5.3 Market Opportunities
- 5.3.1 Technological Advancements and Approvals in Deep Brain Stimulation
- 5.4 Future Trends
- 5.4.1 Growing Research and Development Activities
- 5.5 Impact Analysis
6. Deep Brain Simulation Market - North America Market Analysis
- 6.1 North America Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030
7. North America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Product
- 7.1 Overview
- 7.2 North America Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
- 7.3 Single Channel Deep Brain Stimulator
- 7.3.1 Overview
- 7.3.2 Single Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Dual Channel Deep Brain Stimulator
- 7.4.1 Overview
- 7.4.2 Dual Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5 Software and Accessories
- 7.5.1 Overview
- 7.5.2 Software and Accessories: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Application
- 8.1 Overview
- 8.2 North America Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
- 8.3 Parkinson's Disease
- 8.3.1 Overview
- 8.3.2 Parkinson's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Tremor
- 8.4.1 Overview
- 8.4.2 Tremor: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Alzheimer's Disease
- 8.5.1 Overview
- 8.5.2 Alzheimer's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- 8.6 Dystonia
- 8.6.1 Overview
- 8.6.2 Dystonia: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- 8.7 Epilepsy
- 8.7.1 Overview
- 8.7.2 Epilepsy: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- 8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by End User
- 9.1 Overview
- 9.2 North America Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
- 9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Neurology Clinics
- 9.4.1 Overview
- 9.4.2 Neurology Clinics: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Deep Brain Simulation Market - Country Analysis
- 10.1 Overview
- 10.1.1.1 North America Deep Brain Simulation Market, by Country
- 10.1.1.2 US
- 10.1.1.2.1 Overview
- 10.1.1.2.2 US Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.2.3 US Deep Brain Simulation Market, by Product
- 10.1.1.2.4 US Deep Brain Simulation Market, by Application
- 10.1.1.2.5 US Deep Brain Simulation Market, by End User
- 10.1.1.3 Canada
- 10.1.1.3.1 Overview
- 10.1.1.3.2 Canada Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.3.3 Canada Deep Brain Simulation Market, by Product
- 10.1.1.3.4 Canada Deep Brain Simulation Market, by Application
- 10.1.1.3.5 Canada Deep Brain Simulation Market, by End User
- 10.1.1.4 Mexico
- 10.1.1.4.1 Overview
- 10.1.1.4.2 Mexico Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.4.3 Mexico Deep Brain Simulation Market, by Product
- 10.1.1.4.4 Mexico Deep Brain Simulation Market, by Application
- 10.1.1.4.5 Mexico Deep Brain Simulation Market, by End User
11. Pre & Post Covid-19 Impact
- 11.1 Pre & Post Covid-19 Impact
12. Deep Brain Simulation Market Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in Deep Brain Stimulation Market
- 12.3 Organic Growth Strategies
- 12.3.1 Overview
- 12.4 Inorganic Growth Strategies
- 12.4.1 Overview
13. North America Deep Brain Simulation Market, Key Company Profiles
- 13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Medtronic Plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Boston Scientific Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Newronika SpA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
14. Appendix
- 14.1 About Us
- 14.2 Glossary of Terms
